Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone with or without ethinyl oestradiol in Implanon users
ACTRN12605000698673Phase 3Recruiting
- Sponsor
- FPA Women's Health
- Start
- Aug 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone, ethinyl estradiol, etonogestrel in breakthrough bleeding, sponsored by FPA Women's Health. Started Aug 2005; status: recruiting.
02
Drugs
mifepristoneethinyl estradioletonogestrel
03
Conditions
breakthrough bleeding
Beyond the preview
Go deeper on ACTRN12605000698673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000698673.